Clinical Scorecard: Utilization of Non-Invasive Respiratory Support in ARDS: Insights on Physiology, Challenges, and Strategies for Effective Implementation

At a Glance

Key Highlights

• The optimal patient selection, device or interface choice, and timing of intubation remain unresolved.
• NIV and CPAP can improve oxygenation through PEEP-mediated lung recruitment; hemodynamic effects vary with cardiac function.
• Sustained elevated inspiratory effort during NIV and tidal volumes above 9 mL/kg predicted body weight have been associated with NIV failure or unfavorable outcomes.
• NIV or CPAP may be feasible in carefully selected patients with mild ARDS when hemodynamic instability is absent and mental status is preserved.
• Helmet NIV allows higher PEEP with minimal air leakage, but tidal-volume monitoring is difficult.

Guideline-Based Recommendations

Diagnosis

• The review uses the 2024 Global Definition of ARDS for contemporary clinical practice.
• Interpret study findings in light of enrolled populations, since much of the evidence concerns AHRF or ARDS defined by earlier or study-specific criteria.

Management

• Individualize NIV parameters; the review describes initial PEEP of approximately 5 cm H₂O, increasing to 10 cm H₂O, and pressure support of 5–8 cm H₂O above PEEP.
• Adjust settings promptly according to comfort, respiratory effort, tidal volume, oxygenation, and gas exchange.
• For persistent hypoxemia with helmet NIV, PEEP of 8–12 cm H₂O may be required.
• Consider NIV or CPAP only in carefully selected patients with mild ARDS, preserved mental status, and no hemodynamic instability, as described in the review.

Monitoring & Follow-up

• Assess respiratory effort, tidal volume, oxygenation, gas exchange, and patient comfort during NIV or CPAP.
• Recognize that standardized bedside assessment of inspiratory effort and P-SILI risk, including esophageal pressure monitoring, is limited and not routinely performed.
• Account for interface tolerance, air leaks, and patient–ventilator asynchrony; tidal-volume monitoring is difficult with helmet NIV.

Risks

• Excessive spontaneous inspiratory effort can increase negative pleural pressure swings and regional lung stress, potentially contributing to P-SILI.
• Pressure support and vigorous patient effort can produce large tidal volumes; volumes above 9 mL/kg predicted body weight have been associated with unfavorable outcomes.
• Positive intrathoracic pressure reduces right ventricular preload and pulmonary blood flow; marked reductions in cardiac output may negate oxygenation benefit.
• NIV and CPAP effectiveness may be limited by interface tolerance, air leaks, and patient–ventilator asynchrony.

Patient & Prescribing Data

Patients with ARDS or AHRF; the evidence base includes variable severity and differing radiographic, timing, and eligibility criteria.

NIV, CPAP, and HFNC are discussed as non-invasive support options. NIV/CPAP settings require individual titration, with early reassessment for treatment failure.

Clinical Best Practices

• Balance oxygenation and respiratory-effort reduction against the risk of excessive inspiratory effort and large tidal volumes.
• Titrate PEEP and pressure support to the individual patient and reassess promptly using clinical response and gas exchange.
• Consider cardiac function when evaluating the hemodynamic effects and oxygenation response to positive pressure.
• Interpret evidence according to the population and ARDS criteria used in each study.

Related Resources & Content